The relationship between baseline blood pressure and computed tomography findings in acute stroke: Data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)

Stroke

Volumn 40, Issue 1, 2009, Pages 41-46

  Sare, Gillian M ^a   Bath, Philip M W ^a   Gray, Laura J ^a   Moulin, Thierry ^b   Woimant, France ^c   England, Timothy ^a   Geeganage, Chamila ^a   Christensen, Hanne ^d   De Deyn, Peter Paul ^e   Leys, Didier ^f   O'Neill, Desmond ^g   Ringelstein, E Bernd ^h  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d BISPEBJERG HOSPITAL   (Denmark)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g ADELAIDE AND MEATH HOSPITAL   (Ireland)

^h UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acute stroke; CT; Hypertension; Ischaemia; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; TINZAPARIN; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; BLEEDING; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; HUMAN; HYPERTENSION; INFARCTION; MAJOR CLINICAL STUDY; NEUROIMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; ACUTE DISEASE; BLOOD PRESSURE; BRAIN; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMORBIDITY; EPIDEMIOLOGY; INCIDENCE; LEUKOARAIOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; STROKE; VASCULARIZATION;

ACUTE DISEASE; ASPIRIN; BLOOD PRESSURE; BRAIN; BRAIN ISCHEMIA; CAUSALITY; CEREBRAL HEMORRHAGE; COMORBIDITY; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERTENSION; INCIDENCE; LEUKOARAIOSIS; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60549087724     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.526665     Document Type: Article

References (24)

1. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;33:1315-1320.
2. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension. 2004;43:18-24.
3. Toyoda K, Okada Y, Kobayashi S. Early recurrence of ischemic stroke in Japanese patients: The Japan standard stroke registry study. Cerebrovasc Dis. 2007;24:289-295.
4. Bowes MP, Zivin JA, Thomas GR, Thibodeaux H, Fagan SC. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp Neurol. 1996;141:40-46.
5. Saku Y, Choki J, Waki R, Masuda J, Tamaki K, Fujishima M, Ogata J. Hemorrhagic infarct induced by arterial hypertension in cat brain following middle cerebral artery occlusion. Stroke. 1990;21:589-595.
6. Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: Effect of labetalol. Exp Neurol. 1998;150:153-158.
7. International Stroke Trial Collaborative Group. The international stroke trial (IST); a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
8. Yong M, Kaste M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. Stroke. 2008;39: 366-372.
9. Sprigg N, Gray LJ, Bath PMW, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson J-E, O'Neill D, Ringlestein B, van der Sande J-J, Lindenstrom E, for the TAIST investigators. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: Data from the taist trial. J Hypertens. 2006; 24:1413-1417.
10. Bath P, Lindenstrom E, Boysen G, De Deyn P, Friis P, Leys D, Marttila R, Olsson J-E, O'Neill D, Orgogozo J-M, Ringelstein B, van der Sande J-J, Turpie AGG. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial. Lancet. 2001;358:702-710.
11. The Multicenter Acute Stroke Trial - Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145-150.
12. Hommel M, for The FISS bis Investigators Group. Fraxiparine in ischaemic stroke study (FISS bis). Cerebrovasc Dis. 1998;8:19(abstract).
13. Moulin T, Cattin F, Crepin-Leblond T, Tatu L, Chavot D, Piotin M, Viel JF, Rumbach L, Bonneville JF. Early ct signs in acute middle cerebral artery infarction: Predictive value for subsequent infarct locations and outcome. Neurology. 1996;47:366-375.
14. Moulin T, Crepin-Leblond T, Chopard JL, Bogousslavsky J. Hemor-rhagic infarcts. Eur Neurol. 1994;34:64 -77.
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
16. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, The TOAST Investigators. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
17. Mead GE, Lewis SC, Wardlaw JM, Dennis MS, Warlow CP. How well does the Oxfordshire community stroke project classification predict the site and size of the infarct on brain imaging? J Neurol, Neurosurg Psychiatry. 2000;68:558-562.
18. Christensen H, Meden P, Overgaard K, Boysen G. The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand. 2002;106:142-147.
19. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke. 1999;30:287-292.
20. Khan U, Porteous L, Hassan A, Markus HS. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry. 2007;78:702-706.
21. Fu JH, Lu CZ, Hong Z, Dong Q, Luo Y, Wong KS. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry. 2005;76:793-796.
22. Arboix A, Font A, Garro C, Garca-Eroles L, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: A clinical study of 122 patients. J Neurol Neurosurg Psychiatry. 2007;78: 1392-1394.
23. De Reuck J, Van de Velde E, Van Maele G, Wissaert W. The prognostic significance of changes in x-ray attenuation on ct in established cerebral infarcts. Cerebrovasc Dis. 2003;16:114-121.
24. The ENOS Trial Investigators. Glyceryl trinitrate vs. Control, and continuing vs stopping temporarily prior antihypertensive therapy, in acute stroke: Rationale and design of the efficacy of nitric oxide in stroke (ENOS) trial (ISTCRN99414122). Int J Stroke. 2006;1:245-249.